BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 10905484)

  • 1. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice.
    Fukui Y; Masui S; Osada S; Umesono K; Motojima K
    Diabetes; 2000 May; 49(5):759-67. PubMed ID: 10905484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression.
    Kelly LJ; Vicario PP; Thompson GM; Candelore MR; Doebber TW; Ventre J; Wu MS; Meurer R; Forrest MJ; Conner MW; Cascieri MA; Moller DE
    Endocrinology; 1998 Dec; 139(12):4920-7. PubMed ID: 9832429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes.
    Matsuda J; Hosoda K; Itoh H; Son C; Doi K; Hanaoka I; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Odaka H; Nakao K
    Diabetes; 1998 Nov; 47(11):1809-14. PubMed ID: 9792555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
    Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T
    Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat.
    Emilsson V; O'Dowd J; Wang S; Liu YL; Sennitt M; Heyman R; Cawthorne MA
    Metabolism; 2000 Dec; 49(12):1610-5. PubMed ID: 11145125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of growth hormone (GH) on mRNA levels of uncoupling proteins 1, 2, and 3 in brown and white adipose tissues and skeletal muscle in obese mice.
    Hioki C; Yoshida T; Kogure A; Takakura Y; Umekawa T; Yoshioka K; Shimatsu A; Yoshikawa T
    Horm Metab Res; 2004 Sep; 36(9):607-13. PubMed ID: 15486811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-gamma.
    Kageyama H; Hirano T; Okada K; Ebara T; Kageyama A; Murakami T; Shioda S; Adachi M
    Biochem Biophys Res Commun; 2003 May; 305(1):22-7. PubMed ID: 12732191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of YM440 a hypoglycemic agent on binding to a peroxisome proliferator-activated receptor gamma and its transactivation.
    Kurosaki E; Nakano R; Shimaya A; Yoshida S; Ida M; Suzuki T; Shibasaki M; Shikama H
    Biochem Pharmacol; 2003 Mar; 65(5):795-805. PubMed ID: 12628477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential.
    Dey D; Medicherla S; Neogi P; Gowri M; Cheng J; Gross C; Sharma SD; Reaven GM; Nag B
    Metabolism; 2003 Aug; 52(8):1012-8. PubMed ID: 12898466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level.
    Bakopanos E; Silva JE
    Diabetes; 2000 Dec; 49(12):2108-15. PubMed ID: 11118014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa/fa Zucker rats: comparison to CL 316,243.
    Burkey BF; Dong M; Gagen K; Eckhardt M; Dragonas N; Chen W; Grosenstein P; Argentieri G; de Souza CJ
    Metabolism; 2000 Oct; 49(10):1301-8. PubMed ID: 11079820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes.
    Digby JE; Montague CT; Sewter CP; Sanders L; Wilkison WO; O'Rahilly S; Prins JB
    Diabetes; 1998 Jan; 47(1):138-41. PubMed ID: 9421389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
    Wang M; Wise SC; Leff T; Su TZ
    Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.
    Sakamoto J; Kimura H; Moriyama S; Odaka H; Momose Y; Sugiyama Y; Sawada H
    Biochem Biophys Res Commun; 2000 Nov; 278(3):704-11. PubMed ID: 11095972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
    Berger J; Bailey P; Biswas C; Cullinan CA; Doebber TW; Hayes NS; Saperstein R; Smith RG; Leibowitz MD
    Endocrinology; 1996 Oct; 137(10):4189-95. PubMed ID: 8828476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle.
    Camirand A; Marie V; Rabelo R; Silva JE
    Endocrinology; 1998 Jan; 139(1):428-31. PubMed ID: 9421444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
    Camp HS; Li O; Wise SC; Hong YH; Frankowski CL; Shen X; Vanbogelen R; Leff T
    Diabetes; 2000 Apr; 49(4):539-47. PubMed ID: 10871190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.
    Wang YL; Frauwirth KA; Rangwala SM; Lazar MA; Thompson CB
    J Biol Chem; 2002 Aug; 277(35):31781-8. PubMed ID: 12082115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.